Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer
- PMID: 35232445
- PMCID: PMC8889747
- DOI: 10.1186/s12962-022-00342-7
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer
Abstract
Objective: To appraise the sources of evidence and methods to estimate input parameter values in decision-analytic model-based cost-effectiveness analyses of treatments for primary breast cancer (PBC) in older patients (≥ 70 years old).
Methods: Two electronic databases (Ovid Medline, Ovid EMBASE) were searched (inception until 5 September-2021) to identify model-based full economic evaluations of treatments for older women with PBC as part of their base-case target population or age-subgroup analysis. Data sources and methods to estimate four types of input parameters including health-related quality of life (HRQoL); natural history; treatment effect; resource use were extracted and appraised. Quality assessment was completed by reference to the Consolidated Health Economic Evaluation Reporting Standards.
Results: Seven model-based economic evaluations were included (older patients as part of their base-case (n = 3) or subgroup (n = 4) analysis). Data from younger patients (< 70 years) were used frequently to estimate input parameters. Different methods were adopted to adjust these estimates for an older population (HRQoL: disutility multipliers, additive utility decrements; Natural history: calibration of absolute values, one-way sensitivity analyses; Treatment effect: observational data analysis, age-specific behavioural parameters, plausible scenario analyses; Resource use: matched control observational data analysis, age-dependent follow-up costs).
Conclusion: Improving estimated input parameters for older PBC patients will improve estimates of cost-effectiveness, decision uncertainty, and the value of further research. The methods reported in this review can inform future cost-effectiveness analyses to overcome data challenges for this population. A better understanding of the value of treatments for these patients will improve population health outcomes, clinical decision-making, and resource allocation decisions.
Keywords: Data sources of input parameters; Decision-analytic modelling; Economic evaluation; Older women; Primary breast cancer.
© 2022. The Author(s).
Conflict of interest statement
All authors (Yubo Wang, Sean P Gavan, Douglas Steinke, Kwok-Leung Cheung, and Li-Chia Chen) declare no conflict of interest.
Figures
References
-
- University of Oxfrod GCDL. Our World in Data. 2021 [cited 2021 06 Sep]; https://ourworldindata.org.
-
- Tang SW, et al. Is surgery always indicated in older women with breast cancer? Minerva Chir. 2010;65(5):555–568. - PubMed
-
- Drummond MF, et al. Methods for the economic evaluation of health care programmes. Oxford University Press; 2015.
Publication types
LinkOut - more resources
Full Text Sources
